AlloSource Granted Sixth Patent for AlloTrue

AlloSource remains true to AlloTrue.

The non-profit provider of skin, bone and soft tissue allografts for use in surgical procedures and processor of cellular bone allografts, has received a sixth patent for its proprietary tissue cleaning and disinfecting system.

AlloTrue is a tissue cleaning and disinfecting system that uses rotation, coupled with sonication to reduce bacteria. The technology works by exposing allografts to various cleaning solutions inside a fully-automated, closed rotating canister. In addition to bacteria, AlloTrue removes the marrow and lipids that can be responsible for allograft discoloration.

“Garnering not one but an entire group of patents surrounding the AlloTrue system has been a lengthy process but an important an highly valuable one, due to the nature of AlloTrue,” President/CEOThomas Cycyota said. “This exclusive method of cleaning transplantable tissues allows us to maximize each gift of life donated by generous tissue donors and their families.”

The first AlloTrue patent was issued Feb. 9, 2010.

Based in Centennial, Colo., AlloSource offers more than 200 types of precise bone, skin, soft-tissue and custom-machined allografts for use in various life-saving and life-enhancing medical procedures. The company claims to be the world’s largest processor of cellular bone allografts; it is accredited by the American Association of Tissue Banks.